论文部分内容阅读
为研究评价合并子宫内膜增生对子宫内膜癌的预后价值,比较有无合并子宫内膜增生的病理特征,手术分期和预后,取材于1985～1991年手术治疗子宫内膜癌214例。平均随访64(1～135)个月。分期根据1988年FIGO分期标准。复阅所有病理切片。根据是否合并子宫内膜增生,分为两组。子宫内膜增生分类依据WHO标准。末次月经在5年以内为绝经早期。末次月经在5年以上为绝经晚期。92例(43%)在癌组织相邻部位或癌组织内并存子
In order to evaluate the prognosis of endometrial carcinoma with endometrial hyperplasia, we compared the pathological features, stage and prognosis of endometrial hyperplasia with surgical treatment of 214 cases of endometrial carcinoma from 1985 to 1991. The average follow-up 64 (1 ~ 135) months. Staging According to 1988 FIGO staging criteria. Review all pathological sections. According to whether the merger of endometrial hyperplasia, divided into two groups. Endometrial hyperplasia classification according to WHO standards. The last menstruation within 5 years for the early menopause. The last menstruation in more than 5 years for menopause. Ninety-two (43%) survived adjacent tissues or cancerous tissues